ARCT FY 2025 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$217M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$82M-40.7% YoY

Gross Profit

$00.0% margin

Operating Income

-$76M-93.0% margin

Net Income

$10M12.3% margin

EPS (Diluted)

$-2.40

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$74M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$271M

Total Liabilities

$57M

Stockholders' Equity

$214M

Cash & Equivalents

$231M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$138M	-40.7%
Gross Profit	$0	$138M	-100.0%
Operating Income	-$76M	-$96M	+20.3%
Net Income	$10M	-$81M	+112.5%